首页> 外文期刊>American Journal of PharmTech Research >Formulation and Development of Floating Tablet of Highly Water Soluble Drug Using Combination of Hydrophilic and Hydrophobic Polymers
【24h】

Formulation and Development of Floating Tablet of Highly Water Soluble Drug Using Combination of Hydrophilic and Hydrophobic Polymers

机译:亲水性和疏水性聚合物结合制备高水溶性药物浮片的研制

获取原文
           

摘要

  ABSTRACT Water soluble drugs if not formulated properly, may release the drug at a faster rate and produce a toxic concentration on administration. Captopril belongs to the class I of biopharmaceutical classification system (BCS) has short half life (~2hrs) shows dose dumping, burst and stability in acidic pH of stomach. In this study HPMC K15M and Compritol 888 ATO alone and in combination different proportions using physical mixture and solid dispersion method to prepare floating matrix tablet. The tablets were evaluated for appearance, weight variation, hardness, friability, floating lag time, duration and integrity of matrices, In-vitro and In vivo drug release kinetics. IR spectra, thermal behavior and X-ray diffraction pattern of selected solid dispersions were carried out indicating no degradative changes. The rate of release of Captopril from floating matrix tablets containing physical mixtures was found to be affected by the concentration of Compritol 888 ATO increase in the concentration decrease the release. Among the formulations containing solid dispersions of drug with Compritol888 ATO (SPC3c’’) give retardation of drug release (t90% 12) for extended time. All formulations indicated diffusion exponent (n) values in the range 0.4 to 0.6 suggesting Fickian diffusion. The values of ‘n’ increased with increase in concentration of lipid polymers suggesting a shift in the mechanism of drug release from Fickian to anomalous. All formulations show initial burst release which may due to high water solubility of Captopril. The X-Ray photographs indicated the residence of tablet in stomach for about 5hs. Keywords: Compritol888 ATO; X-ray diffraction; Solid dispersions
机译:摘要水溶性药物如果配制不当,可能会以更快的速度释放药物并在给药时产生毒性浓度。卡托普利属于生物药物分类系统(BCS)的I类,半衰期短(〜2小时),显示出剂量倾倒,爆发和在酸性胃酸中稳定。在这项研究中,单独使用HPMC K15M和Compritol 888 ATO并以不同比例组合使用物理混合物和固体分散法制备浮基质片剂。评价片剂的外观,重量变化,硬度,脆性,漂浮滞后时间,基质的持续时间和完整性,体外和体内药物释放动力学。所选择的固体分散体的红外光谱,热行为和X射线衍射图谱表明没有降解变化。发现卡托普利从含有物理混合物的漂浮基质片剂中的释放速率受Compritol 888 ATO浓度增加的影响,浓度增加会降低释放。在含有药物与Compritol888ATO(SPC3c')的固体分散体的制剂中,延长了药物释放的延迟(t90%> 12)。所有配方均表明扩散指数(n)值在0.4到0.6的范围内,表明Fickian扩散。 “ n”值随脂质聚合物浓度的增加而增加,表明药物释放的机制已从菲克安转变为反常。所有制剂均显示出最初的突释释放,这可能是由于卡托普利的高水溶性所致。 X射线照片显示片剂在胃中停留约5小时。关键字:Compritol888 ATO; X射线衍射;固体分散体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号